A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma

American Journal of Human Genetics

Volumn 72, Issue 1, 2003, Pages 88-100

  Borrego, Salud ^a   Wright, Fred A ^b,d   Fernández, Raquel M ^a   Williams, Nita ^b   López Alonso, Manuel ^a   Davuluri, Ramana ^b   Antiñolo, Guillermo ^a   Eng, Charis ^b,c,e  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d IL   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC CODE; GERM CELL; HAPLOTYPE; HIRSCHSPRUNG DISEASE; HUMAN; INTRON; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTO ONCOGENE; SINGLE NUCLEOTIDE POLYMORPHISM; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA;

EID: 0037217482     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/345466     Document Type: Article

References (60)

1. Amiel J, Atrié T, Jan D, Pelet A, Edery P, Bidaud C, Lacombe D, Tam P, Simeoni J, Flori E, Nihoul-Fékété C, Munnich A, Lyonnet S (1996) Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Hum Mol Genet 5:355-357
2. Amiel J, Espinosa-Parilla Y, Steffan J, Gosset P, Pelet A, Prieru M, Boute O, Choiset A, Lacombe D, Philip N, Le Merrer M, Tanaka H, Till M, Touraine R, Toutain A, Vekemans M, Munnich A, Lyonnet S (2001) Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. Am J Hum Genet 69:1370-1377
3. Angrist M, Bolk S, Halushka M, Lapchak PA, Chakravarti A (1996) Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nat Genet 14:341-344
4. Angrist M, Bolk S, Thiel B, Puffenberger EG, Hofstra RM, Buys CHCM, Cass DT, Chakravarti A (1995) Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet 4:821-830
5. Attié T, Pelet A, Edery P, Eng C, Mulligan LM, Amiel J, Boutrand L, Beldjord C, Nihoul-Fékété C, Munnich A, Ponder BAJ, Lyonnet S (1995) Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet 4:1381-1386
6. Auricchio A, Casari G, Staiano A, Ballabio A (1996) Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population. Hum Mol Genet 5:351-354
7. Badner JA, Sieber WK, Garver KL, Chakravarti A (1990) A genetic study of Hirschsprung disease. Am J Hum Genet 46:568-580
8. Bidaud C, Salomon R, Vancamp G, Pelet A, Attié T, Eng C, Bonduelle M, Amiel J, Nihoul-Fékété C, Willems PJ, Munnich A, Lyonnet S (1997) Endothelin-3 gene mutations in isolated and syndromic Hirschsprung disease. Eur J Hum Genet 5:247-251
9. Bolk S, Pelet A, Hofstra RMW, Angrist M, Salomon R, Croaker D, Buys CHCM, Lyonnet S, Chakravarti A (2000) A human model for multigenic inheritance: Phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci USA 97:268-273
10. Bordeaux MC, Forcet C, Granger L, Corset V, Bidaud C, Billaud M, Bredesen DE, Edery P, Mehlen P (2000) The RET proto-oncogene induces apoptosis: A novel mechanism for Hirschsprung disease. EMBO J 19:4056-4063
11. Borrego S, Eng C, Sánchez B, Sáez M-E, Navarro E, Antiñolo G (1998) Molecular analysis of RET and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease. J Clin Endocrinol Metab 83:3361-3364
12. Borrego S, Saez ME, Ruiz A, Gimm O, Gao X, Lopez-Alonso M, Hernandez A, Wright FA, Antiñolo G, Eng C (2000) RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease. J Med Genet 37:572-578
13. Borrego S, Saez ME, Ruiz A, Gimm O, Lopez-Alonso M, Antiñolo G, Eng C (1999) Specific polymorphisms in the RET proto-oncogene are over-represented in individuals with Hirschsprung disease and may represent loci modifying phenotypic expression. J Med Genet 36:771-774
14. Capes-Davis A, Andrew SD, Hyland VJ, Twigg S, Learoyd DL, Dwight T, Marsh DJ, Robinson BG (1999) Glucocorticoids differentially inhibit expression of the RET proto-oncogene. Gene Expr 8:311-326
15. Carson EB, McMahon M, Baylin SB, Nelkin BD (1995) Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell line differentiation. Cancer Res 55:2048-2052
16. Chakravarti A (1996) Endothelin receptor-mediated signaling in Hirschsprung disease. Hum Mol Genet 5:303-307
17. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES (2001) High resolution haplotype structure in the human genome. Nat Genet 29:229-232
18. de la Chapelle A, Wright FA (1998) Linkage disequilibrium mapping in isolated populations: The example of Finland revisited. Proc Natl Acad Sci USA 95:12416-12423
19. del Tito BJ, Poff HE, Novotny MA, Cartledge DM, Walker RI 2nd, Earl CD, Bailey AL (1998) Automated fluorescent analysis procedure for enzymatic mutation detection. Clin Chem 44:731-739
20. Doray B, Salomon R, Amiel J, Pelet A, Touraine R, Billaud M, Attié T, Bachy B, Munnich A, Lyonnet S (1998) Mutation of the RET ligands, neurturin, supports multigenic inheritance in Hirschsprung disease. Hum Mol Genet 7:1449-1452
21. Dracopoli NH, Haines JL, Korf BR, Moir DT, Morton CC, Seidman CE, Seidman JG, Smith DR (1994) Current Protocols in Human Genetics. Vol. 1. John Wiley and Sons, New York
22. Edery P, Attié T, Amiel J, Pelet A, Eng C, Hofstra RMW, Martelli H, Bidaud C, Munnich A, Lyonnet S (1996) Mutation of the endothelin-3 gene in Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet 12:442-444
23. Edery P, Attié T, Mulligan LM, Pelet A, Eng C, Ponder BAJ, Munnich A, Lyonnet S (1994) A novel polymorphism in the coding sequence of the human RET proto-oncogene. Hum Genet 94:579-580
24. Eng C (1996) The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung disease. N Engl J Med 335:943-951
25. Eng C (1999) RET proto-oncogene in the development of human cancer. J Clin Oncol 17:380-393
26. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, Ploos van Amstel HK, et al (1996a) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis. JAMA 276:1575-1579
27. Eng C, Mulligan LM, Healey CS, Houghton C, Frilling A, Raue F, Thomas GA, Ponder BAJ (1996b) Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma. Cancer Res 56:2167-2170
28. Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HPH, Pfragner R, Behmel A, Lorenzo MJ, Stonehouse TJ, Ponder MA, Ponder BAJ (1995) Mutation in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Genes Chrom Cancer 12:209-212
29. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GFW, Jackson CE, Tunnacliffe A, Ponder BAJ (1994) Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet 3:237-241
30. Falk CT, Rubinstein P (1987) Haplotype relative risks: An easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 51:227-233
31. Fitze G, Schreiber M, Kuhlisch E, Schackert HK, Roesner D (1999) Association of the RET proto-oncogene codon 45 polymorphism with Hirschsprung disease. Am J Hum Genet 65:1469-1473
32. Gao X, Wright FA (1999) Nonparametric disequilibrium mapping when haplotypes are available. Am J Hum Genet Suppl 65:A250
33. Gimm O, Neuberg DS, Marsh DJ, Dahia PLM, Hoang-Vu C, Raue F, Hinze R, Dralle H, Eng C (1999) Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation. Oncogene 18:1369-1370
34. Griseri P, Pesce B, Patrone G, Osinga J, Puppa F, Sancarndi M, Hofstra R, Romeo G, Ravazzolo R, Devoto M, Ceccherini I (2002) A rare haplotype of the RET proto-oncogene is a risk-modifying allele in Hirschsprung disease. Am J Hum Genet 71:969-974
35. Griseri P, Sancandi M, Patrone G, Bocciardi R, Hofstra R, Ravazzolo R, Devoto M, Romeo G, Ceccherini I (2000) A single-nucleotide polymorphic variant of the RET proto-oncogene is underrepresented in sporadic Hirschsprung disease. Eur J Hum Genet 8:721-724
36. Hastbacka J, de la Chapelle A, Kaitila I, Sistonen P, Weaver A, Lander E (1992) Linkage disequilibrium mapping in isolated founder populations: Diastrophic dysplasia in Finland. Nat Genet 2:204-211
37. Hofstra RMW, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Höppener JWM, Ploos van Amstel HK, Romeo G, Lips CJM, Buys CHCM (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375-376
38. Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, Richardsson B, Sigurdardottir S, Barnard J, Hallbeck B, Masson G, Shlien A, Palsson ST, Frigge ML, Thorgeirsson TE, Gulcher JR, Stefansson K (2002) A high-resolution recombination map of the human genome. Nat Genet 31:241-247
39. Lang D, Chen F, Milewski R, Li J, Lu MM, Epstein JA (2000) Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret. J Clin Invest 106:963-971
40. Lyonnet S, Bolino A, Pelet A, Abel L, Nihoul-Fekété C, Briard ML, Mok-Siu V, Kaariainen H, Martucciello G, Lerone M, Puliti A, Luo Y, Weissenbach J, Devoto M, Munnich A, Romeo G (1993) A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet 4:346-350
41. Marcos I, Ruiz A, Blaschak CJ, Borrego S, Cutting GR, Antinolo G (2000) Mutation analysis of GABRR1 and GABRR2 in autosomal recessive retinitis pigmentosa. J Med Genet 37:E5
42. Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE (1998) The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395:801-804
43. Mulligan LM, Gardner E, Smith BA, Mathew CGP, Ponder BAJ (1993) Genetic events in tumor initiation and progression in multiple endocrine neoplasia. Genes Chrom Cancer 6:166-177
44. Ott J (1999) Analysis of Human Genetic Linkage, 3rd Edition. Johns Hopkins Press, Baltimore
45. Pasini B, Borrello MG, Greco A, Bongarzone I, Luo Y, Mondellini P, Alberti C, Miranda C, Arighi E, Bocciardi R, Seri M, Barone V, Radice MT, Romeo G, Pierotti MA (1995) Loss of function effect of RET mutations causing Hirschsprung disease. Nat Genet 10:35-40
46. Passarge E (1967) The genetics of Hirschsprung's disease. N Engl J Med 276:138-141
47. Pelet A, Geneste O, Edery P, Pasini A, Chappuis S, Attié T, Munnich A, Lenoir G, Lyonnet S, Billaud M (1998) Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease. J Clin Invest 101:1415-1423
48. Pingault V, Bondurand N, Kuhlbroadt K, Goerich DE, Préhu M-O, Puliti A, Herbarth B, Hermans-Borgmeyer I, Legius E, Matthijs G, Amiel J, Lyonnet S, Ceccherini I, Romeo G, Clayton Smith J, Read AP, Wegner M, Goossens M (1998) SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 18:171-173
49. Puffenberger EG, Hosoda K, Washington SS, Nakao K, de Wit D, Yanagisawa M, Chakravarti A (1994) A missense mutation of the endothelin B receptor gene in multigenic Hirschsprung's disease. Cell 79:1257-1266
50. Quandt K, Frech K, Karas H, Wingender E, Werner T (1995) MatInd and MatInspector - New fast and versatible tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23:4878-4884
51. Rabizdeh S, Oh J, Zhong LT, Yang J, Bitler CM, Butcher LL, Bredesen DE (1993) Induction of apoptosis by the low-affinity NGF receptor. Science 261:345-348
52. Reeve JP, Rannala B (2002) DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics 18:894-895
53. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M, Kääriäinen H, Martucciello G (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367:377-378
54. Ruiz A, Antiñolo G, Fernandez RM, Eng C, Marcos I, Borrego S (2001) Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population. Clin Endocrinol 55:399-402
55. Santoro M, Rosato R, Grieco M, Berlingieri MT, Luca-Colucci D'Amato G, de Franciscis V, Fusco A (1990) The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5:1595-1598
56. Songyang Z, Carraway III KL, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo MJ, Ponder BAJ, Mayer BJ, Cantley LC (1995) Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536-539
57. Southard-Smith EM, Kos L, Pavan WJ (1998) Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet 18:60-64
58. Svensson P-J, Molander J-L, Eng C, Anvret M, Nordenskjöld A (1998) Low frequency of RET mutations in Hirschsprung disease in Sweden. Clin Genet 54:39-44
59. Terwilliger JD (1995) A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am J Hum Genet 56:777-787
60. Wakamatsu N, Yamada Y, Yamada K, Ono T, Nomura N, Taniguchi H, Kitoh H, Mutoh N, Yamanaka T, Mushiake K, Kato K, Sonata S, Nagaya M (2001) Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease. Nat Genet 27:369-370